Literature DB >> 1437333

Long-term prednisone and azathioprine treatment of a patient with idiopathic pulmonary hemosiderosis.

G A Rossi1, E Balzano, E Battistini, S Oddera, P Marchese, M Acquila, B Fregonese, P G Mori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437333     DOI: 10.1002/ppul.1950130310

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


× No keyword cloud information.
  6 in total

1.  Rapidly progressive course of pauci-immune pulmonary capillaritis in a 70-year-old Asian male refractory to immunosuppression and plasma exchange.

Authors:  Chuan Jiang; Grace Nabila Martinez Pena; Meng Xie; Khalid Gafoor
Journal:  BMJ Case Rep       Date:  2020-03-12

Review 2.  Idiopathic pulmonary hemosiderosis: a review of the treatments used during the past 30 years and future directions.

Authors:  Biplab K Saha; Nils T Milman
Journal:  Clin Rheumatol       Date:  2020-11-12       Impact factor: 3.650

3.  Idiopathic pulmonary hemosiderosis in adults: a case report and review of the literature.

Authors:  Argyris Tzouvelekis; Paschalis Ntolios; Anastasia Oikonomou; Anastasios Koutsopoulos; Efthimios Sivridis; George Zacharis; Kostantinos Kaltsas; Panagiotis Boglou; Dimitrios Mikroulis; Demosthenes Bouros
Journal:  Case Rep Med       Date:  2012-07-18

Review 4.  Idiopathic Pulmonary Hemosiderosis as a Mimic of Pulmonary Vasculitis: A Case Report and Review of the Literature.

Authors:  Mary Buckley; Heather Van Mater
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.919

5.  Idiopathic pulmonary haemosiderosis in paediatric patients: how to make an early diagnosis.

Authors:  Luca Castellazzi; Maria Francesca Patria; Gemma Frati; Andrea Alessandro Esposito; Susanna Esposito
Journal:  Ital J Pediatr       Date:  2016-09-20       Impact factor: 3.288

6.  Clinical characteristics and prognosis of idiopathic pulmonary hemosiderosis in pediatric patients.

Authors:  Yajun Zhang; Fenglan Luo; Nini Wang; Yue Song; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-10-02       Impact factor: 1.573

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.